Auris Medical Holding Stock Current Liabilities
Auris Medical Holding fundamentals help investors to digest information that contributes to Auris Medical's financial success or failures. It also enables traders to predict the movement of Auris Stock. The fundamental analysis module provides a way to measure Auris Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auris Medical stock.
Auris |
Auris Medical Holding Company Current Liabilities Analysis
Auris Medical's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Auris Medical Current Liabilities | 8 M |
Most of Auris Medical's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auris Medical Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Auris Medical Holding has a Current Liabilities of 8 M. This is 99.54% lower than that of the Healthcare sector and 98.53% lower than that of the Biotechnology industry. The current liabilities for all United States stocks is 99.9% higher than that of the company.
Auris Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auris Medical's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Auris Medical could also be used in its relative valuation, which is a method of valuing Auris Medical by comparing valuation metrics of similar companies.Auris Medical is currently under evaluation in current liabilities category among its peers.
Auris Fundamentals
| Return On Equity | -71.91 | |||
| Return On Asset | -21.99 | |||
| Current Valuation | 32.76 M | |||
| Shares Outstanding | 12.87 M | |||
| Shares Owned By Insiders | 5.45 % | |||
| Shares Owned By Institutions | 5.34 % | |||
| Number Of Shares Shorted | 362.97 K | |||
| Price To Earning | (1.05) X | |||
| Price To Book | 2.07 X | |||
| Price To Sales | 224.60 X | |||
| Revenue | 174.47 K | |||
| Gross Profit | 174.47 K | |||
| EBITDA | (5.26 M) | |||
| Net Income | (8.2 M) | |||
| Cash And Equivalents | 11.26 M | |||
| Cash Per Share | 0.88 X | |||
| Total Debt | 523.92 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 3.83 X | |||
| Book Value Per Share | 1.47 X | |||
| Cash Flow From Operations | (4.84 M) | |||
| Short Ratio | 0.15 X | |||
| Earnings Per Share | (1.49) X | |||
| Beta | 1.37 | |||
| Market Capitalization | 39.19 M | |||
| Total Asset | 41 M | |||
| Retained Earnings | (164.84 M) | |||
| Working Capital | 31 M | |||
| Current Asset | 39 M | |||
| Current Liabilities | 8 M | |||
| Z Score | 38.8 |
Thematic Opportunities
Explore Investment Opportunities
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Auris Stock
If you are still planning to invest in Auris Medical Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Auris Medical's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |